(VIANEWS) – GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), MGE Energy (MGEE) are the highest payout ratio stocks on this list.

Here’s the data we’ve collected of stocks with a high payout ratio so far. The payout ratio in itself isn’t a promise of a future good investment but it’s an indicator of whether dividends are being paid and how the company chooses to issue them.

When researching a potential investment, the dividend payout ratio is a good statistic to know so here is a list of some companies with an above 30% payout ratio.

1. GlaxoSmithKline (GSK)

76.6% Payout Ratio

GlaxoSmithKline plc engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally.

Volume

Today’s last reported volume for GlaxoSmithKline is 5430660, 23.01% above its average volume of 4414580.

According to Morningstar, Inc., the next dividend payment is on May 19, 2021, the estimated forward annual dividend rate is 2.17 and the estimated forward annual dividend yield is 5.41%.

GlaxoSmithKline’s sales growth this year is expected to be 5% and 5.5% for next year.

Year-on-year quarterly revenue growth declined by 18.4%, now sitting on 32.43B for the twelve trailing months.

GlaxoSmithKline’s sales growth is 7.9% for the ongoing quarter and 6.6% for the next. The company’s growth estimates for the ongoing quarter and the next is negative 14% and negative -1.6%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 29.04%.

Volatility

GlaxoSmithKline’s last day, week, and month’s current intraday variation average was 1.96%, 2.42%, and 1.35%, respectively.

GlaxoSmithKline’s highest amplitude of average volatility was 1.72% (day), 1.74% (last week), and 1.50% (last month), respectively.

GlaxoSmithKline’s Stock Yearly Top and Bottom Value

GlaxoSmithKline’s stock is valued at $41.86 at 19:23 EST, under its 52-week high of $43.61 and way higher than its 52-week low of $33.53.

GlaxoSmithKline’s Moving Average

GlaxoSmithKline’s value is higher than its 50-day moving average of $39.98 and above its 200-day moving average of $39.80.

Previous days news about GlaxoSmithKline (GSK)

  • According to Bloomberg Quint on Saturday, 26 February, "The vaccine named Covifenz was jointly developed by Medicago Inc., a biopharma company owned by Mitsubishi Chemical and Philip Morris and based in Quebec City, and GlaxoSmithKline Plc. "
  • According to Bloomberg Quint on Friday, 25 February, "The vaccine named Covifenz was jointly developed by Medicago Inc., a biopharma company owned by Mitsubishi Chemical and Philip Morris and based in Quebec City, and GlaxoSmithKline Plc. "
  • According to Bloomberg Quint on Friday, 25 February, "Cipla Ltd., Sun Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., GlaxoSmithKline Pharmaceuticals Ltd., Eris Lifesciences Ltd., AstraZeneca Pharma India Ltd. "
  • According to Benzinga on Friday, 25 February, "Severalformerscientistsand staff from companies like Johnson & Johnson (NYSE:JNJ), GlaxoSmithKline (NYSE:GSK)and Schiff Nutrition are bringing a new delivery platform to market that boosts the bioavailability ofhemp cannabidiolorCBD."
  • According to Bloomberg Quint on Friday, 25 February, "The company, which is partnering with GlaxoSmithKline Plc on the drug, said it supplied the FDA with additional information, including safety data for higher doses, and is awaiting "further correspondence." The FDA didn’t immediately respond to a request for comment."

2. Johnson & Johnson (JNJ)

61.5% Payout Ratio

Johnson & Johnson researches and develops, manufactures, and sells various products in the health care field worldwide.

Volume

Today’s last reported volume for Johnson & Johnson is 6076840, 25.08% below its average volume of 8111540.

As claimed by Morningstar, Inc., the next dividend payment is on Aug 22, 2021, the estimated forward annual dividend rate is 4.24 and the estimated forward annual dividend yield is 2.56%.

Johnson & Johnson’s sales growth this year is anticipated to be 14.1% and 4% for next year.

Year-on-year quarterly revenue growth grew by 27.1%, now sitting on 89.19B for the twelve trailing months.

Johnson & Johnson’s sales growth for the next quarter is 10.4%. The company’s growth estimates for the present quarter and the next is 7.3% and 19.9%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 26.81%.

Volatility

Johnson & Johnson’s last day, week, and month’s current intraday variation average was 4.97%, 2.02%, and 0.99%, respectively.

Johnson & Johnson’s highest amplitude of average volatility was 4.56% (day), 2.40% (last week), and 1.71% (last month), respectively.

Johnson & Johnson’s Stock Yearly Top and Bottom Value

Johnson & Johnson’s stock is valued at $164.57 at 19:23 EST, under its 52-week high of $179.92 and way above its 52-week low of $142.86.

Johnson & Johnson’s Moving Average

Johnson & Johnson’s value is higher than its 50-day moving average of $162.51 and under its 200-day moving average of $167.48.

Previous days news about Johnson & Johnson (JNJ)

  • According to The New York Times on Friday, 25 February, "Through its pharmaceutical division, Janssen, Johnson & Johnson will pay $5 billion, broken into annual payments over nine years. ", "The distributors and Johnson & Johnson released statements Friday morning, noting that the deal is not an admission of wrongdoing and that they strongly dispute the allegations. "

3. MGE Energy (MGEE)

49.92% Payout Ratio

MGE Energy, Inc., through its subsidiaries, operates as a public utility holding company primarily in Wisconsin.

Volume

Today’s last reported volume for MGE Energy is 45354, 38.02% below its average volume of 73182.

As stated by Morningstar, Inc., the next dividend payment is on Nov 29, 2021, the estimated forward annual dividend rate is 1.55 and the estimated forward annual dividend yield is 1.94%.

MGE Energy’s sales growth this year is expected to be 8.8% and 4% for next year.

Year-on-year quarterly revenue growth grew by 7.9%, now sitting on 566.93M for the twelve trailing months.

MGE Energy’s sales growth is 16.9% for the ongoing quarter and negative 6.1% for the next. The company’s growth estimates for the next quarter is negative 1%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.84%.

Volatility

MGE Energy’s last day, week, and month’s current intraday variation average was 0.16%, 0.73%, and 0.80%, respectively.

MGE Energy’s highest amplitude of average volatility was 1.87% (day), 1.72% (last week), and 2.08% (last month), respectively.

MGE Energy’s Stock Yearly Top and Bottom Value

MGE Energy’s stock is valued at $72.99 at 19:23 EST, way under its 52-week high of $82.95 and way higher than its 52-week low of $63.34.

MGE Energy’s Moving Average

MGE Energy’s worth is below its 50-day moving average of $77.58 and below its 200-day moving average of $76.92.

4. ManTech International Corporation (MANT)

42.94% Payout Ratio

ManTech International Corporation provides technology solutions and services for U.S. defense, intelligence community, and federal civilian agencies worldwide.

Volume

Today’s last reported volume for ManTech International Corporation is 259659, 19.62% above its average volume of 217064.

As maintained by Morningstar, Inc., the next dividend payment is on Dec 1, 2021, the estimated forward annual dividend rate is 1.52 and the estimated forward annual dividend yield is 2.03%.

ManTech International Corporation’s sales growth this year is expected to be 1.8% and 2.3% for next year.

Year-on-year quarterly revenue growth grew by 0.3%, now sitting on 2.56B for the twelve trailing months.

ManTech International Corporation’s sales growth is 1.1% for the ongoing quarter and 4.8% for the next. The company’s growth estimates for the present quarter and the next is negative 4.5% and negative -6.8%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.66%.

Volatility

ManTech International Corporation’s last day, week, and month’s current intraday variation average was 2.02%, 1.47%, and 1.98%, respectively.

ManTech International Corporation’s highest amplitude of average volatility was 2.54% (day), 2.90% (last week), and 4.04% (last month), respectively.

ManTech International Corporation’s Stock Yearly Top and Bottom Value

ManTech International Corporation’s stock is valued at $81.97 at 19:23 EST, way below its 52-week high of $92.00 and way higher than its 52-week low of $66.91.

ManTech International Corporation’s Moving Average

ManTech International Corporation’s worth is way above its 50-day moving average of $73.31 and above its 200-day moving average of $80.13.

5. NortonLifeLock (NLOK)

40.65% Payout Ratio

NortonLifeLock Inc. provides cyber safety solutions for consumers worldwide.

Volume

Today’s last reported volume for NortonLifeLock is 6781180, 51.72% above its average volume of 4469460.

As stated by Morningstar, Inc., the next dividend payment is on Aug 19, 2021, the estimated forward annual dividend rate is 0.5 and the estimated forward annual dividend yield is 1.96%.

NortonLifeLock’s sales growth this year is anticipated to be 9.8% and 10.6% for next year.

Year-on-year quarterly revenue growth grew by 11.7%, now sitting on 2.62B for the twelve trailing months.

The company’s growth estimates for the ongoing quarter and the next is 16.7% and 13.2%.

Volatility

NortonLifeLock’s last day, week, and month’s current intraday variation average was 1.86%, 3.14%, and 1.99%, respectively.

NortonLifeLock’s highest amplitude of average volatility was 3.52% (day), 4.53% (last week), and 3.28% (last month), respectively.

NortonLifeLock’s Stock Yearly Top and Bottom Value

NortonLifeLock’s stock is valued at $28.98 at 19:23 EST, higher than its 52-week high of $28.92.

NortonLifeLock’s Moving Average

NortonLifeLock’s value is way above its 50-day moving average of $25.22 and way above its 200-day moving average of $24.90.

6. Trustmark Corporation (TRMK)

39.32% Payout Ratio

Trustmark Corporation operates as the bank holding company for Trustmark National Bank that provides banking and other financial solutions to individuals and corporate institutions in the United States.

Volume

Today’s last reported volume for Trustmark Corporation is 251993, 5.3% below its average volume of 266104.

According to Morningstar, Inc., the next dividend payment is on Feb 27, 2022, the estimated forward annual dividend rate is 0.92 and the estimated forward annual dividend yield is 2.83%.

Trustmark Corporation’s sales growth this year is expected to be negative 2.5% and 8.4% for next year.

Year-on-year quarterly revenue growth declined by 10.7%, now sitting on 676.41M for the twelve trailing months.

Trustmark Corporation’s sales growth is negative 8.3% for the current quarter and negative 8.5% for the next. The company’s growth estimates for the ongoing quarter and the next is negative 51.2% and negative -38.2%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.46%.

Volatility

Trustmark Corporation’s last day, week, and month’s current intraday variation average was 0.03%, 0.92%, and 1.17%, respectively.

Trustmark Corporation’s highest amplitude of average volatility was 2.58% (day), 2.26% (last week), and 3.37% (last month), respectively.

Trustmark Corporation’s Stock Yearly Top and Bottom Value

Trustmark Corporation’s stock is valued at $32.48 at 19:23 EST, way under its 52-week high of $36.31 and way above its 52-week low of $28.81.

Trustmark Corporation’s Moving Average

Trustmark Corporation’s value is below its 50-day moving average of $32.90 and higher than its 200-day moving average of $32.22.

LEAVE A REPLY

Please enter your comment!
Please enter your name here